Plasma neutrophil gelatinase-associated lipocalin as a biomarker for acute kidney injury in critically ill patients with suspected sepsis

Clinical Biochemistry

Volumn 46, Issue 15, 2013, Pages 1414-1418

  Kim, Hanah ^a   Hur, Mina ^a   Cruz, Dinna N ^b   Moon, Hee Won ^a   Yun, Yeo Min ^a  

^a Konkuk University School of Medicine   (South Korea)

^b UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

Acute kidney injury; Neutrophil gelatinase associated lipocalin; Procalcitonin; Sepsis

Indexed keywords

BIOLOGICAL MARKER; NEUTROPHIL GELATINASE ASSOCIATED LIPOCALIN; PROCALCITONIN;

ACUTE KIDNEY FAILURE; ADOLESCENT; ADULT; AGED; ARTICLE; CHILD; CONCENTRATION (PARAMETERS); CRITICALLY ILL PATIENT; DIAGNOSTIC PROCEDURE; EMERGENCY HEALTH SERVICE; FEMALE; HUMAN; INFANT; MAJOR CLINICAL STUDY; MALE; NEWBORN; PRESCHOOL CHILD; PRIORITY JOURNAL; SCHOOL CHILD; SEPSIS; SEPTIC SHOCK; SEQUENTIAL ORGAN FAILURE ASSESSMENT SCORE;

ACUTE KIDNEY INJURY; NEUTROPHIL GELATINASE-ASSOCIATED LIPOCALIN; PROCALCITONIN; SEPSIS;

ACUTE KIDNEY INJURY; ACUTE-PHASE PROTEINS; ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; CALCITONIN; CHILD; CHILD, PRESCHOOL; CRITICAL ILLNESS; FEMALE; HUMANS; INFANT; INFANT, NEWBORN; LIPOCALINS; MALE; MIDDLE AGED; PREDICTIVE VALUE OF TESTS; PROTEIN PRECURSORS; PROTO-ONCOGENE PROTEINS; REAGENT KITS, DIAGNOSTIC; SEPSIS; SEVERITY OF ILLNESS INDEX;

EID: 84884350782     PISSN: 00099120     EISSN: 18732933     Source Type: Journal    
DOI: 10.1016/j.clinbiochem.2013.05.069     Document Type: Article

References (30)

1. Levy M.M., Fink M.P., Marshall J.C., Abraham E., Angus D., Cook D., et al. 2001 SCCM/ESICM/ACCP/ATS/SIS International Sepsis Definitions Conference. Crit Care Med 2003, 31:1250-1256.
2. Rangel-Frausto M.S., Pittet D., Costigan M., Hwang T., Davis C.S., Wenzel R.P. The natural history of the systemic inflammatory response syndrome (SIRS). A prospective study. JAMA 1995, 273:117-123.
3. Winters B.D., Eberlein M., Leung J., Needham D.M., Pronovost P.J., Sevransky J.E. Long-term mortality and quality of life in sepsis: a systematic review. Crit Care Med 2010, 38:1276-1283.
4. Assicot M., Gendrel D., Carsin H., Raymond J., Guilbaud J., Bohuon C. High serum procalcitonin concentrations in patients with sepsis and infection. Lancet 1993, 341:515-518.
5. Tang B.M., Eslick G.D., Craig J.C., McLean A.S. Accuracy of procalcitonin for sepsis diagnosis in critically ill patients: systematic review and meta-analysis. Lancet Infect Dis 2007, 7:210-217.
6. Hur M., Moon H.W., Yun Y.M., Kim K.H., Kim H.S., Lee K.M. Comparison of diagnostic utility between procalcitonin and C-reactive protein for the patients with blood culture-positive sepsis. Korean J Lab Med 2009, 29:529-535.
7. Vincent J.L., Moreno R., Takala J., Willatts S., De Mendonça A., Bruining H., et al. The SOFA (Sepsis-related Organ Failure Assessment) score to describe organ dysfunction/failure. On behalf of the Working Group on Sepsis-Related Problems of the European Society of Intensive Care Medicine. Intensive Care Med 1996, 22:707-710.
8. Bagshaw S.M., Mortis G., Doig C.J., Godinez-Luna T., Fick G.H., Laupland K.B. One-year mortality in critically ill patients by severity of kidney dysfunction: a population-based assessment. Am J Kidney Dis 2006, 48:402-409.
9. Coca S.G., Yusuf B., Shlipak M.G., Garg A.X., Parikh C.R. Long-term risk of mortality and other adverse outcomes after acute kidney injury: a systematic review and meta-analysis. Am J Kidney Dis 2009, 53:961-973.
10. Molitoris B.A., Okusa M.D., Palevsky P.M., Chawla L.S., Kaufman J.S., Devarajan P., et al. Design of clinical trials in AKI: a report from an NIDDK workshop. Trials of patients with sepsis and in selected hospital settings. Clin J Am Soc Nephrol 2012, 7:856-860.
11. Cunningham P.N., Dyanov H.M., Park P., Wang J., Newell K.A., Quigg R.J. Acute renal failure in endotoxemia is caused by TNF acting directly on TNF receptor-1 in kidney. J Immunol 2002, 168:5817-5823.
12. Payen D., Lukaszewicz A.C., Legrand M., Gayat E., Faivre V., Megarbane B., et al. A multicentre study of acute kidney injury in severe sepsis and septic shock: association with inflammatory phenotype and HLA genotype. PLoS One 2012, 7:e35838.
13. Lerolle N., Nochy D., Guérot E., Bruneval P., Fagon J.Y., Diehl J.L., et al. Histopathology of septic shock induced acute kidney injury: apoptosis and leukocytic infiltration. Intensive Care Med 2010, 36:471-478.
14. Mehta R.L., Kellum J.A., Shah S.V., Molitoris B.A., Ronco C., Warnock D.G., et al. Acute Kidney Injury Network: report of an initiative to improve outcomes in acute kidney injury. Crit Care 2007, 11:R31.
15. Mishra J., Ma Q., Prada A., Mitsnefes M., Zahedi K., Yang J., et al. Identification of neutrophil gelatinase-associated lipocalin as a novel early urinary biomarker for ischemic renal injury. J Am Soc Nephrol 2003, 14:2534-2543.
16. Mishra J., Dent C., Tarabishi R., Mitsnefes M.M., Ma Q., Kelly C., et al. Neutrophil gelatinase-associated lipocalin (NGAL) as a biomarker for acute renal injury after cardiac surgery. Lancet 2005, 365:1231-1238.
17. Schmidt-Ott K.M., Mori K., Kalandadze A., Li J.Y., Paragas N., Nicholas T., et al. Neutrophil gelatinase-associated lipocalin-mediated iron traffic in kidney epithelia. Curr Opin Nephrol Hypertens 2006, 15:442-449.
18. Soni S.S., Pophale R., Ronco C. New biomarkers for acute renal injury. Clin Chem Lab Med 2011, 49:1257-1263.
19. Hawkins R. New biomarkers of acute kidney injury and the cardio-renal syndrome. Korean J Lab Med 2011, 31:72-80.
20. Cruz D.N., de Cal M., Garzotto F., Perazella M.A., Lentini P., Corradi V., et al. Plasma neutrophil gelatinase-associated lipocalin is an early biomarker for acute kidney injury in an adult ICU population. Intensive Care Med 2010, 36:444-451.
21. Ronco C., Cruz D., Noland B.W. Neutrophil gelatinase-associated lipocalin curve and neutrophil gelatinase-associated lipocalin extended-range assay: a new biomarker approach in the early diagnosis of acute kidney injury and cardio-renal syndrome. Semin Nephrol 2012, 32:121-128.
22. Haase M., Bellomo R., Devarajan P., Schlattmann P., Haase-Fielitz A. Accuracy of neutrophil gelatinase-associated lipocalin (NGAL) in diagnosis and prognosis in acute kidney injury: a systematic review and meta-analysis. Am J Kidney Dis 2009, 54:1012-1024. NGAL Meta-analysis Investigator Group.
23. Moran S.M., Myers B.D. Course of acute renal failure studied by a model of creatinine kinetics. Kidney Int 1985, 27:928-937.
24. Devarajan P. Neutrophil gelatinase-associated lipocalin (NGAL): a new marker of kidney disease. Scand J Clin Lab Invest Suppl 2008, 241:89-94.
25. Kellum J.A., Bellomo R., Ronco C. Definition and classification of acute kidney injury. Nephron Clin Pract 2008, 109:c182-c187.
26. Ympa Y.P., Sakr Y., Reinhart K., Vincent J.L. Has mortality from acute renal failure decreased? A systematic review of the literature. Am J Med 2005, 118:827-832.
27. Lameire N., Van Biesen W., Vanholder R. The changing epidemiology of acute renal failure. Nat Clin Pract Nephrol 2006, 2:364-377.
28. Clec'h C., Gonzalez F., Lautrette A., Nguile-Makao M., Garrouste-Orgeas M., Jamali S., et al. Multiple-center evaluation of mortality associated with acute kidney injury in critically ill patients: a competing risks analysis. Crit Care 2011, 15:R128.
29. Lopes J.A., Jorge S., Resina C., Santos C., Pereira A., Neves J., et al. Acute renal failure in patients with sepsis. Crit Care 2007, 11:411.
30. Tokés-Füzesi M., Woth G., Ernyey B., Vermes I., Mühl D., Bogár L., et al. Microparticles and acute renal dysfunction in septic patients. J Crit Care 2013, 28:141-147.